跨国药企高层：进博会强大“溢出效应”成全球创新成果落地“加速器”

中国新闻网2025-10-23

中新网上海10月23日电 (记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。　　第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。“中国是吉利德科学全球...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2577307068?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-10-23 21:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577307068","market":"us","top_or_hot":-1,"title":"跨国药企高层：进博会强大“溢出效应”成全球创新成果落地“加速器”","media":"中国新闻网","content":"<div>\n<p>中新网上海10月23日电 (记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。　　第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。“中国是吉利德科学全球...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202510233542559744.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>跨国药企高层：进博会强大“溢出效应”成全球创新成果落地“加速器”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n跨国药企高层：进博会强大“溢出效应”成全球创新成果落地“加速器”\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-23 21:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202510233542559744.html><strong>中国新闻网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>中新网上海10月23日电 (记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。　　第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。“中国是吉利德科学全球...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202510233542559744.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"http://finance.eastmoney.com/a/202510233542559744.html","article_id":"2577307068","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510233542559744.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2577307068","pubTimestamp":1761224803,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"中新网上海10月23日电(记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4583":"猴痘概念","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","PBC":"Prospect Capital Corp","BK4532":"文艺复兴科技持仓","GILD":"吉利德科学","SG9999015978.USD":"利安颠覆性创新基金A","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0882574055.USD":"富达全球健康医疗A ACC","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU0058720904.USD":"联博国际健康护理基金A","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4566":"资本集团","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","BK4578":"CAR-T","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","BK4550":"红杉资本持仓","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4568":"美国抗疫概念","BK4588":"碎股","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD"},"translate_title":"Senior executives of multinational pharmaceutical companies: China International Import Expo's strong \"spillover effect\" has become an \"accelerator\" for global innovation achievements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PBC":1,"GILD":0.9},"content_text":"中新网上海10月23日电 (记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。　　第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。“中国是吉利德科学全球核心战略市场之一，我们深切感受到中国营商环境的持续优化，也充分体会到进博会这一开放平台推动创新合作的力量。”金方千表示。　　吉利德科学以“创造一个更健康的世界”为主题，在500平方米的展台上，集中展示其创新产品和研发进展，并分享企业在提升药物可及、推动健康公平等方面的重要成果。金方千指出：“今年，我们再赴进博会之约，期待借助此次盛会，继续深化与社会各界的合作，共同推动中国健康事业发展，书写美美与共的时代新篇。”　　当日，记者了解到，长效HIV暴露前预防药物来那帕韦(Lenacapavir)将在进博会上首次展出。据介绍，来那帕韦是全球同类首创、一年仅需给药两次的长效HIV衣壳抑制剂。在去年进博会上，吉利德科学披露了来那帕韦用于HIV暴露前预防的三期临床数据。今年，这一创新药物在海南博鳌乐城国际医疗旅游先行区获批作为HIV暴露前预防用药，实现“全球同步”准入。　　将在今年进博会上亮相的罕见病新药Seladelpar在去年进博会完成中国首秀，今年8月通过北京临床急需临时进口政策，在北京天竺罕见病药品保障先行区获批，用于与熊去氧胆酸(UDCA)联合治疗UDCA应答不佳的胆汁性胆管炎(PBC)成人患者。　　在金方千看来，作为高水平开放的重要平台，进博会的强大“溢出效应”已成为推动全球创新成果落地的“加速器”。据介绍，吉利德已在中国获批的13款创新药物今年将“齐聚”第八届进博会展台。此外，用于病毒性肝炎治疗的丙通沙®(索磷布韦维帕他韦片)、韦立得®(富马酸丙酚替诺福韦片)、HIV领域的必妥维®(比克恩丙诺片)等创新药物惠及患者的最新进展也将悉数呈现。　　据悉，如今，进博会已经成为吉利德科学扩大“朋友圈”的重要平台。过去三年，吉利德在进博会上累计达成二十余项合作，这些项目的落地进一步推动了国内诊疗水平的提升，促进创新药物可及，助力患者的疾病管理与治疗更加规范。　　首次参加进博会，吉利德科学与中国预防性病艾滋病基金会签署了为期三年的战略合作协议，支持基金会在全国范围内发起实施既往报告丙肝病例随访管理项目。4月，双方又签署了为期三年的二期战略合作协议，旨在帮助更多患者获得治愈、回归健康生活。今年，吉利德科学将在进博会展示多方合作成果的同时，也将举办十余场展台活动，聚焦提升药物可及、助力规范诊疗等多个维度。　　在采访中，金方千表示，吉利德科学将与中国“十五五”新征程同频共振，关注中国患者尚未被满足的医疗需求，持续引进更多全球领先的创新药物，携手多方为“健康中国”建设贡献力量。(完)（文章来源：中国新闻网）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577307068","isCrawlerRequest":true}